Contact Imprint Company: Corporate About HAL Allergies Products R&D Careers News State of the Art Allergy Treatments Leading in allergen immunotherapy HAL Allergy Group (HAL Allergy) is active in the field of biopharmaceuticals and is located at the Bio Science Park in Leiden (NL). HAL Allergy originally stems from 'Haarlems Allergenen Laboratorium', a Dutch company set up in Haarlem. Our core businesses focus on the diagnostic & treatment of allergies and on contract manufacturing with a specialization on the pharmaceutical development and production of batches for preclinical and clinical studies. All of our activities are targeting to achieve the goal of providing the best possible medical products and scientific output in order to increase quality of life for allergic patients and to serve our professional customers. With offices across Europe, HAL Allergy is one of the leading companies in the field of allergen immunotherapy (AIT). Established in 1959 we have long experience in developing, producing and selling allergy therapies that may reduce or erase allergic reactions. The allergy therapies are used against common allergies such as hay fever, house dust mites allergy and allergic reactions towards wasp or bee stings. HAL Allergy is a subsidiary of the family owned Droege Group International AG. News & Events myAllergy geht online – Neue Informationsplattform rund um Allergien mit Fachwissen und Expertenrat 28.09.2016 - Jeder dritte Deutsche wird im Laufe seines Lebens mit dem Thema... HAL Allergy has successfully completed the First-In-Human study with their subcutaneous immunotherapeutic drug for peanut allergy. The study was conducted in Denmark and showed very encouraging results which... HAL Allergy has successfully completed its Phase III short-term efficacy trial with its sublingual allergen immunotherapy (SLIT) liquid product for the treatment of birch pollen allergy. The positive results of this pivotal study will support HAL Allergy to obtain... View more Allergy Calendar Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec Hazel Alder Willow Elm Ash Hornbeam Birch Oak Beech Pine High Level Middle Level © HAL Allergy Group, 2016 ∙ All rights reserved About HAL Our Strategy Businesses International Production Responsibility Management Allergies Causes of Allergies Clinical Conditions Immune System Diagnosis Insights Products SCIT SLIT Diagnostic R&D Clinical Trials Product Pipeline Product Quality Scientific Advisory Board Careers Working at HAL Vacancies Process News Contact Imprint Terms of use Privacy Statement General Conditions